Ads
related to: vertex pharmaceuticals- Contact Us
Find all the ways to reach us
for the information you need.
- Our Company
Learn about our mission and
the values that drive us.
- News
Stay current on all things Vertex
and discover the latest news.
- Our Unique Approach
See What Makes Us Unique
And How We Put Science First.
- Contact Us
Search results
Why Cathie Wood's Darling Crispr Has Tumbled For Five Weeks Straight
Investor's Business Daily· 10 hours agoCrispr Therapeutics (CRSP) and Vertex Pharmaceuticals (VRTX) gained Food and Drug Administration...
ARK Investment Management LLC Boosts Stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
ETF DAILY NEWS· 23 hours agoARK Investment Management LLC grew its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 7.7% in the fourth quarter, according ...
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Purchased by Raymond James & Associates
ETF DAILY NEWS· 3 days agoRaymond James & Associates increased its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 0.0% during the fourth ...
Brokers Suggest Investing in Vertex (VRTX): Read This Before Placing a Bet
Zacks via Yahoo Finance· 17 hours agoAccording to the average brokerage recommendation (ABR), one should invest in Vertex (VRTX). It is...
Vertex Pharmaceuticals (VRTX) Rises As Market Takes a Dip: Key Facts
Zacks via Yahoo Finance· 3 days agoVertex Pharmaceuticals (VRTX) closed the most recent trading day at $416.03, moving +0.09% from the...
Vertex (VRTX) Kidney Disease Drug to Enter Clinical Development
Zacks via Yahoo Finance· 7 days agoVertex Pharmaceuticals Incorporated VRTX announced that the FDA has cleared its investigational new...
Vertex (VRTX) Continues to Diversify Beyond CF Franchise
Zacks via Yahoo Finance· 4 days agoVertex Pharmaceuticals Incorporated VRTX enjoys a dominant position in the cystic fibrosis (CF)...
Three top U.S. biotech stocks to buy in April
Invezz· 17 hours agoMorningstar strategist says Biotech industry has found footing again. Vertex, Neurocrine, and Moderna are three biotech stocks worth owning.
Should You Invest in the iShares Biotechnology ETF (IBB)?
Zacks via Yahoo Finance· 20 hours agoThis ETF has heaviest allocation in the Healthcare sector--about 99.90% of the portfolio. Looking at...
Negative sentiment towards VRTX reflected by a jump of 18.27% in short interest – Knox Daily
Knox Daily· 7 days agoBefore that, Sachdev Amit had sold 3,004 shares from its account. As published in their initiating research note from Wolfe Research on February 15, 2024, Vertex ...
Ads
related to: vertex pharmaceuticals